Skip to content

Author

Yu-Xin Wang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Harnessing machine learning, docking and molecular dynamics for the virtual screening of compounds as CDK4/6 dual inhibitors.

It is elucidated that HY-18,623 achieves high-affinity binding through persistent hydrogen bonds with hinge residues Val96 (CDK4) and Val101 (CDK6) and Val101 (CDK6) as a promising lead candidate for further therapeutic development in oncology.

Yu-Xin Wang, Lin-Xia Fang, Quan-Fang Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.